Shield Test Kits IHS1522255
Summary
AI-generated · Feb 13, 2026Solicitation for 120 units of The ShieldTM blood tester, a non-invasive, FDA-approved screening option for colorectal cancer in individuals at average risk. This kit is intended to serve as a screening tool to identify potential CRC risk in typical screening populations.
120 each The ShieldTM blood tester, a non-invasive screening option FDA approved for individuals at average risk for Colorectal cancer (CRC)
From Special Notice posted on Feb 12, 2026120 each The ShieldTM blood tester, a non-invasive screening option FDA approved for individuals at average risk for Colorectal cancer (CRC)
From Special Notice posted on Feb 18, 2026Notice history
2-
Special Notice Posted Feb 12, 2026
-
Special Notice LATEST Posted Feb 18, 2026No changes from previous notice
Details
Award Information
Not yet awarded
Contacts
Phone
Agency
Place of Performance
USA